South America Synthetic Biology Market Forecast to 2028

Report Code : BMIRE00025393 | Region : LAMEA | Industry : Biotechnology | Published Date : 15/Jul/2022
South America Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)

The SAM synthetic biology market is expected to grow from US$ 450.24 million in 2021 to US$ 1,514.03 million by 2028; it is estimated to grow at a CAGR of 18.9% from 2021 to 2028.

Synthetic biology is an emerging concept that has numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer gene synthesis products/services for biological processes. For example, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcriptis (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products. Amid the adverse effects of the COVID-19 pandemic on start-up performance, the bioeconomy accelerated in the first half of 2020. 56 synthetic biology businesses raised more than US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion during the same period in 2020. The new generation of biopharma businesses uses synthetic biology to improve cell treatment and gene therapy and support early cancer detection. With such rising investments by companies, the demand for synthetic biology-based new techniques is increasing, thereby driving the synthetic biology market growth across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM synthetic biology market . The SAM synthetic biology market is expected to grow at a notable CAGR during the forecast period.

SAM Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

SAM Synthetic Biology Market Segmentation

The SAM synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. The SAM synthetic biology market is segmented into Brazil, Argentina, and Rest of SAM.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the SAM synthetic biology market.

The List of Companies - South America Synthetic Biology Market

● Agilent Technologies, Inc.

● Amyris

● Codexis

● Genscript Biotech corporation

● Integrated DNA Technologies

● Merck KGaA

● New England Biolabs

● Novozymes A/S

● Thermo Fisher Scientific

● Twist Bioscience

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Synthetic Biology Market – By Product

1.3.2 SAM Synthetic Biology Market – By Technology

1.3.3 SAM Synthetic Biology Market – By Application

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Synthetic Biology Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Synthetic Biology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Investments in Synthetic Biology

5.1.2 Rising Number of Start-Ups

5.2 Key Market Restraints

5.2.1 Renewed Regulations for Biotechnology

5.3 Key Market Opportunities

5.3.1 Collaboration Between Companies

5.4 Future Trends

5.4.1 Advanced Synthetic Biology

5.5 Impact Analysis

6. Synthetic Biology Market– SAM Analysis

6.1 SAM Synthetic Biology Market Revenue Forecast and Analysis

7. SAM Synthetic Biology Market Analysis – By Product

7.1 Overview

7.2 SAM Synthetic Biology Market, By Product, 2021 & 2028 (%)

7.3 Enzymes

7.3.1 Overview

7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Oligonucleotides

7.4.1 Overview

7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Chassis Organisms

7.5.1 Overview

7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Xeno-Nucleic Acids

7.6.1 Overview

7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

8. SAM Synthetic Biology Market Analysis – By Technology

8.1 Overview

8.2 SAM Synthetic Biology Market Share by Technology - 2021 & 2028 (%)

8.3 Gene Synthesis

8.3.1 Overview

8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genome Engineering

8.4.1 Overview

8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.5 Measurement and Modeling

8.5.1 Overview

8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.6 Cloning and Sequencing

8.6.1 Overview

8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.7 Nanotechnology

8.7.1 Overview

8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Synthetic Biology Market Analysis – By Application

9.1 Overview

9.2 SAM Synthetic Biology Market Share by Application - 2021 & 2028 (%)

9.3 Medical Applications

9.3.1 Overview

9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.1 Drug Discovery and Therapeutics

9.3.2.1.1 Overview

9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.2 Pharmaceuticals

9.3.2.2.1 Overview

9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.4 Industrial Applications

9.4.1 Overview

9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.5 Food & Agriculture

9.5.1 Overview

9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.6 Environmental Applications

9.6.1 Overview

9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Synthetic Biology Market – Country Analysis

10.1 SAM: Synthetic Biology Market

10.1.1 Overview

10.1.2 SAM: Synthetic Biology Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.1.1 Overview

10.1.2.1.2 Brazil: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.1.3 Brazil: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.1.4 Brazil: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.1.5 Brazil: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.6 Brazil: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.1.7 Brazil: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.2 Argentina: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.2.1 Overview

10.1.2.2.2 Argentina: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.2.3 Argentina: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.2.4 Argentina: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.2.5 Argentina: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.6 Argentina: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.3 Rest of SAM: Synthetic Biology Market - Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 Overview

10.1.2.3.2 Rest of SAM: Synthetic Biology Market - Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3 Rest of SAM: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.3.4 Rest of SAM: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.3.5 Rest of SAM: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.6 Rest of SAM: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Agilent Technologies, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MERCK KGaA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 New England Biolabs

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Integrated DNA Technologies

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Twist Bioscience

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 GenScript Biotech Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Novozymes A/S

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Codexis

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Amyris Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. SAM Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2. Brazil: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 3. Brazil: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 4. Brazil: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 5. Argentina: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 6. Argentina: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 7. Argentina: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 8. Argentina: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 9. Rest of SAM: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 10.   Rest of SAM: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 11.   Rest of SAM: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 12.   Rest of SAM: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 13.   Organic Developments

Table 14.   Inorganic Developments

Table 15.   Glossary of Terms

The List of Companies - South America Synthetic Biology Market

● Agilent Technologies, Inc.

● Amyris

● Codexis

● Genscript Biotech corporation

● Integrated DNA Technologies

● Merck KGaA

● New England Biolabs

● Novozymes A/S

● Thermo Fisher Scientific

● Twist Bioscience

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM synthetic biology market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(South America Synthetic Biology Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry